Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
Clinical trial NCT07525466 · RECRUITING
Trial details
- NCT number
- NCT07525466
- Sponsor
- Beijing Tongren Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.